Autonomix Medical, Inc. financial data

Symbol
AMIX on Nasdaq
Location
The Woodlands, TX
Fiscal year end
31 March
Latest financial report
10-Q - Q4 2025 - 11 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 539% % -20%
Debt-to-equity 23% % -29%
Return On Equity -338% % 8.4%
Return On Assets -276% % 1.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11,409,344 shares 363%
Common Stock, Shares, Outstanding 11,409,344 shares 363%
Entity Public Float $8,113,215 USD
Common Stock, Value, Issued $11,000 USD 450%
Weighted Average Number of Shares Outstanding, Basic 8,955,809 shares 384%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD
Research and Development Expense $7,237,000 USD 87%
General and Administrative Expense $10,313,000 USD 50%
Operating Income (Loss) $17,550,000 USD -63%
Nonoperating Income (Expense) $309,000 USD 134%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $17,241,000 USD -27%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $25,458,000 USD -7.7%
Earnings Per Share, Basic -3.34 USD/shares 62%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $9,934,000 USD -16%
Other Assets, Current $257,000 USD 136%
Assets, Current $10,191,000 USD -15%
Property, Plant and Equipment, Net $20,000 USD 0%
Assets $10,211,000 USD -15%
Accounts Payable, Current $714,000 USD 208%
Accrued Liabilities, Current $936,000 USD 6.2%
Liabilities, Current $1,650,000 USD -27%
Liabilities $1,650,000 USD -27%
Retained Earnings (Accumulated Deficit) $64,427,000 USD -37%
Stockholders' Equity Attributable to Parent $8,561,000 USD -12%
Liabilities and Equity $10,211,000 USD -15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,604,000 USD -41%
Net Cash Provided by (Used in) Financing Activities $2,057,000 USD
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 11,409,344 shares 363%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $547,000 USD 71%
Deferred Tax Assets, Valuation Allowance $5,723 USD 65%
Deferred Tax Assets, Gross $6,029 USD 74%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards $761 USD -71%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $72,977,000 USD 28%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $3,000 USD -93%
Deferred Tax Assets, Net of Valuation Allowance $306 USD
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%